OBJECTIVE: To evaluate a multipronged approach to promote dual contraceptive use by women within heterosexual HIV-1-serodiscordant partnerships. METHODS: For 213 HIV-1-serodiscordant couples in Thika, Kenya, participating in an HIV-1 prevention clinical trial, contraceptive promotion was initiated through amultipronged intervention that included staff training, couples family planning sessions, and free provision of hormonal contraception on-site. Contraceptive use and pregnancy incidence were compared between two time periods (before versus after June 2007, when the intervention was initiated) and between Thika and other Kenyan trial sites (Eldoret, Kisumu, and Nairobi). Generalized estimating equations and Andersen-Gill proportional hazards modeling were used. RESULTS: Nonbarrier contraceptive use increased after implementation of the intervention: from 31.5 to 64.7% of visits among HIV-1-seropositive women [odds ratio 4.0, 95% confidence interval (CI) 3.0-5.3] and from 28.6 to 46.7% of visits among HIV-1-seronegative women (odds ratio 2.2, 95% CI 1.4-3.5). In comparison, at the other Kenyan sites, where the intervention was not implemented, contraceptive use changed minimally, from 15.6 to 22.3% of visits for HIV-1-seropositive women and from 13.6 to 12.7% among HIV-1-seronegative women. Self-reported condom use remained high during follow-up. Pregnancy incidence at the Thika was significantly lower after compared with before June 2007 (hazard ratio 0.2, 95% CI 0.1-0.6) and was approximately half that at other Kenyan sites during the intervention period (hazard ratio 0.5, 95% CI 0.3-0.8). CONCLUSION: A multipronged family planning intervention can lead to high nonbarrier contraceptive uptake and reduced pregnancy incidence among women in HIV-1-serodiscordant partnerships.
RCT Entities:
OBJECTIVE: To evaluate a multipronged approach to promote dual contraceptive use by women within heterosexual HIV-1-serodiscordant partnerships. METHODS: For 213 HIV-1-serodiscordant couples in Thika, Kenya, participating in an HIV-1 prevention clinical trial, contraceptive promotion was initiated through a multipronged intervention that included staff training, couples family planning sessions, and free provision of hormonal contraception on-site. Contraceptive use and pregnancy incidence were compared between two time periods (before versus after June 2007, when the intervention was initiated) and between Thika and other Kenyan trial sites (Eldoret, Kisumu, and Nairobi). Generalized estimating equations and Andersen-Gill proportional hazards modeling were used. RESULTS: Nonbarrier contraceptive use increased after implementation of the intervention: from 31.5 to 64.7% of visits among HIV-1-seropositivewomen [odds ratio 4.0, 95% confidence interval (CI) 3.0-5.3] and from 28.6 to 46.7% of visits among HIV-1-seronegative women (odds ratio 2.2, 95% CI 1.4-3.5). In comparison, at the other Kenyan sites, where the intervention was not implemented, contraceptive use changed minimally, from 15.6 to 22.3% of visits for HIV-1-seropositivewomen and from 13.6 to 12.7% among HIV-1-seronegative women. Self-reported condom use remained high during follow-up. Pregnancy incidence at the Thika was significantly lower after compared with before June 2007 (hazard ratio 0.2, 95% CI 0.1-0.6) and was approximately half that at other Kenyan sites during the intervention period (hazard ratio 0.5, 95% CI 0.3-0.8). CONCLUSION: A multipronged family planning intervention can lead to high nonbarrier contraceptive uptake and reduced pregnancy incidence among women in HIV-1-serodiscordant partnerships.
Authors: Karen E Mark; Jareen Meinzen-Derr; Rob Stephenson; Alan Haworth; Yusuf Ahmed; Dana Duncan; Andrew Westfall; Susan Allen Journal: J Womens Health (Larchmt) Date: 2007-10 Impact factor: 2.681
Authors: Jaco Homsy; Rebecca Bunnell; David Moore; Rachel King; Samuel Malamba; Rose Nakityo; David Glidden; Jordan Tappero; Jonathan Mermin Journal: PLoS One Date: 2009-01-08 Impact factor: 3.240
Authors: Jairam R Lingappa; Barrot Lambdin; Elizabeth Ann Bukusi; Kenneth Ngure; Linda Kavuma; Mubiana Inambao; William Kanweka; Susan Allen; James N Kiarie; Joseph Makhema; Edwin Were; Rachel Manongi; David Coetzee; Guy de Bruyn; Sinead Delany-Moretlwe; Amalia Magaret; Nelly Mugo; Andrew Mujugira; Patrick Ndase; Connie Celum Journal: PLoS One Date: 2008-01-09 Impact factor: 3.240
Authors: Rena Patel; Sarah Baum; Daniel Grossman; Rachel Steinfeld; Maricianah Onono; Craig Cohen; Elizabeth Bukusi; Sara Newmann Journal: AIDS Patient Care STDS Date: 2014-06-13 Impact factor: 5.078
Authors: Rob Stephenson; Bellington Vwalika; Lauren Greenberg; Yusuf Ahmed; Cheswa Vwalika; Elwyn Chomba; William Kilembe; Amanda Tichacek; Susan Allen Journal: J Womens Health (Larchmt) Date: 2011-03-16 Impact factor: 2.681
Authors: Kenneth Ngure; Renee Heffron; Nelly R Mugo; Connie Celum; Craig R Cohen; Josephine Odoyo; Helen Rees; James N Kiarie; Edwin Were; Jared M Baeten Journal: AIDS Date: 2012-02-20 Impact factor: 4.177
Authors: Kathryn Curran; Jared M Baeten; Thomas J Coates; Ann Kurth; Nelly R Mugo; Connie Celum Journal: Curr HIV/AIDS Rep Date: 2012-06 Impact factor: 5.071
Authors: Renee Heffron; Deborah Donnell; Helen Rees; Connie Celum; Nelly Mugo; Edwin Were; Guy de Bruyn; Edith Nakku-Joloba; Kenneth Ngure; James Kiarie; Robert W Coombs; Jared M Baeten Journal: Lancet Infect Dis Date: 2011-10-03 Impact factor: 25.071